Specialty Pharmacy Videos

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.
A look at last week's top stories in the world of pharmacy.
Marc O’Connor, chief operating officer at Curant Health, highlights upcoming trends to pay attention to within the specialty pharmacy landscape.
Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses the importance of pharmacy residency programs.
Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.
Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.
A look at the top stories in pharmacy last week.
Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

Peer Exchange

PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
Lee S. Schwartzberg, MD; Dawn Dolan, PharmD, BCOP; Howard Levine, PharmD; Eric Roeland, MD; and Beth Eaby-Sandy, CRNP, OCN, review the role of 5-HT3 receptor antagonists in treating chemotherapy-induced nausea and vomiting in moderately emetic chemotherapy.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
In this segment, Lee S. Schwartzberg, MD; Beth Eaby-Sandy, CRNP, OCN; Howard Levine, PharmD; Eric Roeland, MD; and Dawn Dolan, PharmD, BCOP, share their views on whether or not to treat chemotherapy-induced nausea and vomiting due to immunotherapy and targeted therapy.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
Dawn Dolan, PharmD, BCOP; Howard Levine, PharmD; Eric Roeland, MD; and Lee S. Schwartzberg, MD, provide insight on different patient education tools and modes of communication for the identification and treatment of chemotherapy-induced nausea and vomiting.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
In this segment, Dawn Dolan, PharmD, BCOP; Beth Eaby-Sandy, CRNP, OCN; Eric Roeland, MD; and Lee S. Schwartzberg, MD, discuss patient risk factors to consider when treating chemotherapy-induced nausea and vomiting.

Insights

INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, discusses the future treatment options for rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, reviews the methodology, results, and clinical importance of the TEAR trial for rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, describes the use of biologics to treat rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, details the roles of both oral and subcutaneous methotrexate in the treatment of rheumatoid arthritis.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$